← Eichor
Condition: Migraine In Adults Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Migraine In Adults

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Puberty, Testosterone, and Brain Development
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT06670053TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME）
Phase 3 · 6 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT05484349Sleep, Stress and Migraine - an Observational and Training Study
NA · 1 location(s) · Susanne Wegener · NCT07573488Vitamin K2 Supplementation in Adult Episodic Migraine
NA · 1 location(s) · Sola Aoun Bahous, M.D. Ph.D. · NCT05943457Emgality for Migraine in Breastmilk
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06085144A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Phase 4 · 1 location(s) · Antonios Likourezos · NCT06473597Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase
Phase N/A · 3 location(s) · AbbVie · NCT07310290A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Phase 2 · 166 location(s) · Ipsen · NCT06625060Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
Phase 4 · 1 location(s) · Medstar Health Research Institute · NCT07301008Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06322407Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Preve
Phase N/A · 36 location(s) · AbbVie · NCT06603558Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder De
Phase 2 · 6 location(s) · Aspeya, Inc. · NCT07646613Neuro-Complex & Multi Supplements for Migraine Prevention
NA · 1 location(s) · Benfida, a department of Handi-Move · NCT07015411Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults
Phase 2 · 1 location(s) · Sichuan Purity Pharmaceutical Technology Co., Ltd. · NCT07304518Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD
NA · 1 location(s) · Karolinska Institutet · NCT07348783Study of EVO756 in Adults With Migraine
Phase 2 · 14 location(s) · Evommune, Inc. · NCT07616128A Pragmatic Trial of Machine Prescription for Migraine
Phase N/A · 1 location(s) · Norwegian University of Science and Technology · NCT06893874A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Phase 4 · 7 location(s) · Pfizer · NCT07609914A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · 54 location(s) · AbbVie · NCT06602479BOTOX® vs. XEOMIN® for Chronic Migraine
Phase 3 · 1 location(s) · Naval Medical Center Camp Lejeune · NCT05598723A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine
NA · 1 location(s) · St. Olavs Hospital · NCT06554886A Study to Compare the Blood Levels of Two Dosage Formulations of the Study Medicine in Healthy Adults
Phase 1 · 1 location(s) · Pfizer · NCT07594769
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.